2004

Apr 20, 2004
Guidant Completes Acquisition of Bioabsorbable Stent Company

Innovative Technology Could Represent New Frontier in Treatment of Heart Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced the $6 million...

Apr 19, 2004
Guidant to Host Live Webcast of its First Quarter Earnings Conference Call

Indianapolis - As previously announced, Guidant Corporation (NYSE: GDT) will conduct a live webcast of its first quarter 2004 earnings conference call on Thursday, April 22 at 11:00 a.m. EDT. The...

Apr 20, 2004
Guidant Completes Acquisition of Bioabsorbable Stent Company
Apr 19, 2004
Guidant to Host Live Webcast of its First Quarter Earnings Conference Call
Apr 7, 2004
Guidant Announces U.S. Approval of Next Generation Implantable Defibrillator

World''s Smallest, Thinnest Defibrillator Offers Advanced Rhythm Discrimination and Industry-Leading Longevity Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader...

Apr 7, 2004
Bernard E. Kury to Join Guidant as Vice President and General Counsel

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Bernard E. Kury will join Guidant as vice president and general counsel, effective April 12. Kury will report to Ronald W....

Apr 6, 2004
Guidant Announces Preliminary First Quarter Sales of $934 million

Reflects Strength Across Major Product Lines; Company Announces Live Webcast of its First Quarter Earnings Conference Call Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced...

Apr 5, 2004
Guidant Announces Enrollment of First Patient in FUTURE III Clinical Trial in Europe

Everolimus Eluting Stent Trial Will Provide Additional Safety and Performance Data Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that the first...

Apr 1, 2004
Guidant Announces Completion of Enrollment in SPIRIT FIRST Everolimus Eluting Stent Trial

Important Milestone Achieved in Guidant''s Everolimus Eluting Stent Program; Next-Generation Drug Eluting Stent Utilizes Company''s VISION Cobalt Chromium Stent Technology Indianapolis, Ind., and...

Mar 9, 2004
Guidant Applauds Government-Supported Heart Failure Trial

Results Will Broaden Patient Population Who Clearly Benefit from an Implantable Defibrillator Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...

Show 5102550100 per page
Top